2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline

C70H42N6 — CID 137458955

IUPAC2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline
SMILESCn1cnc2ccc(-c3cccc(-c4ccc5ccc6c(-c7cnc8c(ccc9ccc(-c%10cc(-c%11ccc%12c(ccc%13c%14ccccc%14ccc%12%13)c%11)cc%11ccncc%10%11)nc98)c7)cc7ccccc7c6c5c4)n3)cc21
InChIInChI=1S/C70H42N6/c1-76-40-73-66-28-22-49(37-67(66)76)64-12-6-11-63(74-64)48-15-13-42-18-26-58-59(34-45-8-3-5-10-55(45)68(58)60(42)35-48)52-33-50-16-14-43-21-27-65(75-70(43)69(50)72-38-52)61-36-51(32-47-29-30-71-39-62(47)61)44-19-23-54-46(31-44)20-25-56-53-9-4-2-7-41(53)17-24-57(54)56/h2-40H,1H3
InChIKeyXHUULMYKAZVZOB-UHFFFAOYSA-N
MW967.15 g/mol
LogP17.87
Rot. Bonds5

About 2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline

2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline (PubChem CID 137458955) has the molecular formula C70H42N6 and a molecular weight of 967.15 g/mol. Its IUPAC name is 2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline.

Molecular Properties

Compound Name2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline
PubChem CID137458955
Molecular FormulaC70H42N6
Molecular Weight967.15 g/mol
Exact Mass966.35
IUPAC Name2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline
SMILESCn1cnc2ccc(-c3cccc(-c4ccc5ccc6c(-c7cnc8c(ccc9ccc(-c%10cc(-c%11ccc%12c(ccc%13c%14ccccc%14ccc%12%13)c%11)cc%11ccncc%10%11)nc98)c7)cc7ccccc7c6c5c4)n3)cc21
InChIInChI=1S/C70H42N6/c1-76-40-73-66-28-22-49(37-67(66)76)64-12-6-11-63(74-64)48-15-13-42-18-26-58-59(34-45-8-3-5-10-55(45)68(58)60(42)35-48)52-33-50-16-14-43-21-27-65(75-70(43)69(50)72-38-52)61-36-51(32-47-29-30-71-39-62(47)61)44-19-23-54-46(31-44)20-25-56-53-9-4-2-7-41(53)17-24-57(54)56/h2-40H,1H3
InChIKeyXHUULMYKAZVZOB-UHFFFAOYSA-N
XLogP17.87
TPSA69.38 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds5
Heavy Atoms76
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500967.15
LogP ≤ 517.87
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline?
The IUPAC name of 2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline (CID 137458955) is 2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline.
What is the SMILES notation for 2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline?
The canonical SMILES for 2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline is Cn1cnc2ccc(-c3cccc(-c4ccc5ccc6c(-c7cnc8c(ccc9ccc(-c%10cc(-c%11ccc%12c(ccc%13c%14ccccc%14ccc%12%13)c%11)cc%11ccncc%10%11)nc98)c7)cc7ccccc7c6c5c4)n3)cc21.
What is the InChIKey of 2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline?
The InChIKey is XHUULMYKAZVZOB-UHFFFAOYSA-N. The full InChI is InChI=1S/C70H42N6/c1-76-40-73-66-28-22-49(37-67(66)76)64-12-6-11-63(74-64)48-15-13-42-18-26-58-59(34-45-8-3-5-10-55(45)68(58)60(42)35-48)52-33-50-16-14-43-21-27-65(75-70(43)69(50)72-38-52)61-36-51(32-47-29-30-71-39-62(47)61)44-19-23-54-46(31-44)20-25-56-53-9-4-2-7-41(53)17-24-57(54)56/h2-40H,1H3.
What are the key properties of 2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline?
2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline has a molecular weight of 967.15 g/mol, XLogP of 17.87, 5 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline is sourced from PubChem (CID 137458955), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).